why choose us

First received: March 13, 2023

Clinical Trial: Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas

Study Status: Completed

Recruit Status: RECRUITING

Condition: This Study Aims to Reveal the Effectiveness, Accuracy, and Feasibility in Bile

Study Type: OBSERVATIONAL


Official Title: A Single-Center Exploratory Study to Assess the Feasibility in Bile cfDNA of Resectable Biliary Tract Carcinomas by Using Burning Rock Gene Testing Platform

Brief Summary: This study intends to use Onconscreen plus 520 Panel (Burning Rock, China) to conduct NGS testing in matched tissue, blood , and bile samples of patients with Resectable Biliary Tract Carcinomas?BTC?.In order to explore thefeasibility in bile cfDNA of BTC?we will collect relevant clinical information and follow-up treatment information.This study aims to reveal the effectiveness, accuracy, and feasibility in bile, as compared to tissues and blood samples.

Read more